Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview

References

• Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg 2014 Sep; 55(3):69-85.
   PubMedGoogle Scholar
• Fiore AE, Bridges CB, Katz JM, Cox NJ. Inactivated influenza vaccines. In (Eds. Plotkin SA, Orenstein WA, Offit PA): Vaccines. Sixth edition. Section 2: Licensed vaccines. 2013; 257-93. Elsevier, ISBN: 978-1-4557-0090-5
   Google Scholar
• Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008 Apr 1; 167(7):775-85; http://dx.doi.org/10.1093/aje/kwm375
   PubMed Web of Science ®Google Scholar
• Gasparini R, Amicizia D, Lai PL, Panatto D. Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly. Hum Vaccin Immunother 2012 Jan; 8(1):21-8; http://dx.doi.org/10.4161/hv.8.1.17622
   PubMed Web of Science ®Google Scholar
• de Francisco Shapovalova N, Donadel M, Jit M, Hutubessy R. A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine 2015 Nov 27; 33(48):6537-44; http://dx.doi.org/10.1016/j.vaccine.2015.10.066
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Influenza (Seasonal), factsheet n° 211. Available at http://​www.​who.​int/​mediacentre/​factsheets/​fs211/​en/​
   Google Scholar
• Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 1933; ii:66-88; http://dx.doi.org/10.1016/S0140-6736(00)78541-2
   Google Scholar
• Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus. J Prev Med Hyg 2014 Dec; 55(4):109-29
   PubMedGoogle Scholar
• Shen Z, Lou K, Wang W. New small-molecule drug design strategies for fighting resistant influenza A. Acta Pharm Sin B 2015 Sep; 5(5):419-30; http://dx.doi.org/10.1016/j.apsb.2015.07.006
   PubMed Web of Science ®Google Scholar
• Treanor JJ. Prospects for Broadly Protective Influenza Vaccines. Am J Prev Med 2015 Dec; 49(6 Suppl 4):S355-63; http://dx.doi.org/10.1016/j.amepre.2015.09.012
   PubMed Web of Science ®Google Scholar
• Stöhr K, Kieny MP, Wood D. Influenza pandemic vaccines: how to ensure a low-cost, low-dose option. Nat Rev Microbiol 2006 Aug; 4(8):565-6; http://dx.doi.org/10.1038/nrmicro1482
   PubMed Web of Science ®Google Scholar
• Gasparini R, Amicizia D, Lai PL, Panatto D. Aflunov(®): a prepandemic influenza vaccine. Expert Rev Vaccines 2012 Feb; 11(2):145-57; http://dx.doi.org/10.1586/erv.11.170
   PubMed Web of Science ®Google Scholar
• He F, Leyrer S, Kwang J. Strategies towards universal pandemic influenza vaccines. Expert Rev Vaccines 2015 Dec 5:1-11. [Epub ahead of print]
   Web of Science ®Google Scholar
• Cox MM, Hollister JR. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals 2009 Jun; 37(3):182-9; http://dx.doi.org/10.1016/j.biologicals.2009.02.014
   PubMed Web of Science ®Google Scholar
• Cox MM, Izikson R, Post P, Dunkle L. Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults. Ther Adv Vaccines 2015 Jul; 3(4):97-108; http://dx.doi.org/10.1177/2051013615595595
   PubMedGoogle Scholar
• Cox MM, Patriarca PA, Treanor J. FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respir Viruses 2008 Nov; 2(6):211-9; http://dx.doi.org/10.1111/j.1750-2659.2008.00053.x
   PubMed Web of Science ®Google Scholar
• Yang LP. Recombinant trivalent influenza vaccine (flublok(®)): a review of its use in the prevention of seasonal influenza in adults. Drugs 2013 Aug; 73(12):1357-66; http://dx.doi.org/10.1007/s40265-013-0103-6
   PubMed Web of Science ®Google Scholar
• Manini I, Domnich A, Amicizia D, Rossi S, Pozzi T, Gasparini R, Panatto D, Montomoli E. Flucelvax (Optaflu) for seasonal influenza. Expert Rev Vaccines 2015 Jun; 14(6):789-804; http://dx.doi.org/10.1586/14760584.2015.1039520
   PubMed Web of Science ®Google Scholar
• McKeage K. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B. Drugs 2013 Sep; 73(14):1587-94; http://dx.doi.org/10.1007/s40265-013-0114-3
   PubMed Web of Science ®Google Scholar
• McKeage K. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B. Drugs 2013 Sep; 73(14):1587-94; http://dx.doi.org/10.1007/s40265-013-0114-3
   PubMed Web of Science ®Google Scholar
• Curran MP, Leroux-Roels I. Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly. Drugs 2010 Aug 20; 70(12):1519-43; http://dx.doi.org/10.2165/11205020-000000000-00000
   PubMed Web of Science ®Google Scholar
• El Sahly HM, Keitel WA. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine. Expert Rev Vaccines 2008 Aug; 7(6):713-9; http://dx.doi.org/10.1586/14760584.7.6.713
   PubMed Web of Science ®Google Scholar
• Rose GW, Cooper CL. Fluarix, inactivated split-virus influenza vaccine. Expert Opin Biol Ther 2006 Mar; 6(3):301-10; http://dx.doi.org/10.1517/14712598.6.3.301
   PubMed Web of Science ®Google Scholar
• Gasparini R, Lai P. Utility of virosomal adjuvated influenza vaccines: a review of the literature. J Prev Med Hyg 2010 Mar; 51(1):1-6
   PubMedGoogle Scholar
• Childress BC, Montney JD, Albro EA. Making evidence-based selections of influenza vaccines. Hum Vaccin Immunother 2014; 10(9):2729-32; PMID:25483499; http://dx.doi.org/10.4161/hv.29340
   PubMed Web of Science ®Google Scholar
• Gasparini R, Amicizia D, Lai PL, Panatto D. Live attenuated influenza vaccine–a review. J Prev Med Hyg 2011 Sep; 52(3):95-101
   PubMedGoogle Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012 Jan; 12(1):36-44; http://dx.doi.org/10.1016/S1473-3099(11)70295-X
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010 Feb 17; (2):CD004876.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). FluVaxView. Available at http://www.cdc.gov/flu/fluvaxview/
   Google Scholar
• Atmar RL, Patel SM, Keitel WA. Intanza(®): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines 2010; 9:1399-409; PMID:21105776; http://dx.doi.org/10.1586/erv.10.134
   PubMed Web of Science ®Google Scholar
• Clayville LR. Influenza update: a review of currently available vaccines. P T 2011 Oct; 36(10):659-84
   PubMedGoogle Scholar
• Foy JE, Hendriksz T, Malouf P, Tobin A. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators. J Am Osteopath Assoc 2013 Feb; 113(2):134-43.
   PubMedGoogle Scholar
• Icardi G, Orsi A, Ceravolo A, Ansaldi F. Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system. Hum Vaccin Immunother 2012 Jan; 8(1):67-75; http://dx.doi.org/10.4161/hv.8.1.18419
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Durando P, Icardi G. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin Biol Ther 2011 Mar; 11(3):415-27; http://dx.doi.org/10.1517/14712598.2011.557658
   PubMed Web of Science ®Google Scholar
• Sullivan SJ, Jacobson R, Poland GA. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Rev Vaccines 2010 Oct; 9(10):1127-33; http://dx.doi.org/10.1586/erv.10.117
   PubMed Web of Science ®Google Scholar
• Sticchi L, Alberti M, Alicino C, Crovari P. The intradermal vaccination: past experiences and current perspectives. J Prev Med Hyg 2010 Mar; 51(1):7-14
   PubMedGoogle Scholar
• Hickling JK, Jones KR, Friede M, Zehrung D, Chen D, Kristensen D. Intradermal delivery of vaccines: potential benefits and current challenges. Bull World Health Organ 2011 Mar 1; 89(3):221-6; http://dx.doi.org/10.2471/BLT.10.079426
   PubMed Web of Science ®Google Scholar
• Di Meglio P, Perera GK, Nestle FO. The multitasking organ: recent insights into skin immune function. Immunity 2011 Dec 23; 35(6):857-69; http://dx.doi.org/10.1016/j.immuni.2011.12.003
   PubMed Web of Science ®Google Scholar
• Menon GK, Cleary GW, Lane ME. The structure and function of the stratum corneum. Int J Pharm 2012 Oct 1; 435(1):3-9; http://dx.doi.org/10.1016/j.ijpharm.2012.06.005
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006 Dec; 1758(12):2080-95; http://dx.doi.org/10.1016/j.bbamem.2006.06.021
   PubMed Web of Science ®Google Scholar
• Gill HS, Kang SM, Quan FS, Compans RW. Cutaneous immunization: an evolving paradigm in influenza vaccines. Expert Opin Drug Deliv 2014 Apr; 11(4):615-27; http://dx.doi.org/10.1517/17425247.2014.885947
   PubMed Web of Science ®Google Scholar
• Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 2008 Jun 19; 26(26):3197-208; http://dx.doi.org/10.1016/j.vaccine.2008.03.095
   PubMed Web of Science ®Google Scholar
• Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol 2014 May; 14(5):289-301; http://dx.doi.org/10.1038/nri3646
   PubMed Web of Science ®Google Scholar
• Richmond JM, Harris JE. Immunology and skin in health and disease. Cold Spring Harb Perspect Med 2014 Dec 1; 4(12):a015339; http://dx.doi.org/10.1101/cshperspect.a015339
   PubMed Web of Science ®Google Scholar
• Bos JD, Kapsenberg ML. The skin immune system Its cellular constituents and their interactions. Immunol Today 1986 Jul-Aug; 7(7-8):235-40; http://dx.doi.org/10.1016/0167-5699(86)90111-8
   PubMedGoogle Scholar
• Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 1983 Jun; 80 Suppl:12s-16s
   PubMed Web of Science ®Google Scholar
• Boltjes A, van Wijk F. Human dendritic cell functional specialization in steady-state and inflammation. Front Immunol 2014 Apr 1; 5:131.
   PubMed Web of Science ®Google Scholar
• Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka AK, Reiter Y, Banchereau J, Ueno H. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008 Sep 19; 29(3):497-510; http://dx.doi.org/10.1016/j.immuni.2008.07.013
   PubMed Web of Science ®Google Scholar
• Clausen BE, Stoitzner P. Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses. Front Immunol 2015 Oct 22; 6:534.
   PubMed Web of Science ®Google Scholar
• Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012; 30:1-22; PMID:22136168; http://dx.doi.org/10.1146/annurev-immunol-100311-102839
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Weber F. Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccin Immunother 2013 Jan; 9(1):115-21; http://dx.doi.org/10.4161/hv.22342
   PubMed Web of Science ®Google Scholar
• Al-Zahrani S, Zaric M, McCrudden C, Scott C, Kissenpfennig A, Donnelly RF. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv 2012 May; 9(5):541-50; http://dx.doi.org/10.1517/17425247.2012.676038
   PubMed Web of Science ®Google Scholar
• Tozuka M, Oka T, Jounai N, Egawa G, Ishii KJ, Kabashima K, Takeshita F. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine. J Dermatol Sci 2016 Apr; 82(1):38-45; http://dx.doi.org/10.1016/j.jdermsci.2015.11.008
   Web of Science ®Google Scholar
• Depelsenaire AC, Meliga SC, McNeilly CL, Pearson FE, Coffey JW, Haigh OL, Flaim CJ, Frazer IH, Kendall MA. Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol 2014 Sep; 134(9):2361-70; http://dx.doi.org/10.1038/jid.2014.174
   PubMed Web of Science ®Google Scholar
• Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12:991-1045; PMID:8011301; http://dx.doi.org/10.1146/annurev.iy.12.040194.005015
   PubMed Web of Science ®Google Scholar
• Matzinger P. The danger model: a renewed sense of self. Science 2002 Apr 12; 296(5566):301-5; http://dx.doi.org/10.1126/science.1071059
   PubMed Web of Science ®Google Scholar
• Smith-Norowitz TA, Kusonruksa M, Wong D, Norowitz MM, Joks R, Durkin HG, Bluth MH. Long-term persistence of IgE anti-influenza A HIN1 virus antibodies in serum of children and adults following influenza A vaccination with subsequent H1N1 infection: a case study. J Inflamm Res 2012; 5:111-6; PMID:23097613; http://dx.doi.org/10.2147/JIR.S34152
   PubMedGoogle Scholar
• Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine 2012 Jan 11; 30(3):523-38; http://dx.doi.org/10.1016/j.vaccine.2011.11.020
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, Compans RW, Skountzou I. Targeting the skin for microneedle delivery of influenza vaccine. Adv Exp Med Biol 2013; 785:121-32; PMID:23456844; http://dx.doi.org/10.1007/978-1-4614-6217-0_13
   PubMed Web of Science ®Google Scholar
• Pettis RJ, Harvey AJ. Microneedle delivery: clinical studies and emerging medical applications. Ther Deliv 2012 Mar; 3(3):357-71; http://dx.doi.org/10.4155/tde.12.13
   PubMedGoogle Scholar
• Hultström M, Roxhed N, Nordquist L. Intradermal insulin delivery: a promising future for diabetes management. J Diabetes Sci Technol 2014 May; 8(3):453-7; http://dx.doi.org/10.1177/1932296814530060
   PubMedGoogle Scholar
• Narayan RJ. Transdermal delivery of insulin via microneedles. J Biomed Nanotechnol 2014 Sep; 10(9):2244-60; http://dx.doi.org/10.1166/jbn.2014.1976
   PubMed Web of Science ®Google Scholar
• Senti G, Kündig TM. Novel Delivery Routes for Allergy Immunotherapy: Intralymphatic, Epicutaneous, and Intradermal. Immunol Allergy Clin North Am 2016 Feb; 36(1):25-37; http://dx.doi.org/10.1016/j.iac.2015.08.006
   PubMed Web of Science ®Google Scholar
• Spanos S, Booth R, Koenig H, Sikes K, Gracely E, Kim IK. Jet Injection of 1% buffered lidocaine versus topical ELA-Max for anesthesia before peripheral intravenous catheterization in children: a randomized controlled trial. Pediatr Emerg Care 2008; 24(8):511-5; PMID:18645542; http://dx.doi.org/10.1097/PEC.0b013e31816a8d5b
   PubMed Web of Science ®Google Scholar
• Ferayorni A, Yniguez R, Bryson M, Bulloch B. Needle-free jet injection of lidocaine for local anesthesia during lumbar puncture: a randomized controlled trial. Pediatr Emerg Care 2012; 28(7):687-90; PMID:22743744; http://dx.doi.org/10.1097/PEC.0b013e31825d210b
   PubMed Web of Science ®Google Scholar
• Cázares-Delgadillo J, Ganem-Rondero A, Kalia YN. Human growth hormone: new delivery systems, alternative routes of administration, and their pharmacological relevance. Eur J Pharm Biopharm 2011 Jun; 78(2):278-88; http://dx.doi.org/10.1016/j.ejpb.2011.01.006
   PubMed Web of Science ®Google Scholar
• Fabi S, Sundaram H. The potential of topical and injectable growth factors and cytokines for skin rejuvenation. Facial Plast Surg 2014 Apr; 30(2):157-71; http://dx.doi.org/10.1055/s-0034-1372423
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007 Dec 17; 25(52):8833-42; http://dx.doi.org/10.1016/j.vaccine.2007.10.020
   PubMed Web of Science ®Google Scholar
• Alarcon JB, Hartley AW, Harvey NG, Mikszta JA. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 2007 Apr; 14(4):375-81; http://dx.doi.org/10.1128/CVI.00387-06
   PubMed Web of Science ®Google Scholar
• Kim Y-C, Park J-H, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Del Rev 2012; 64:1547-68; http://dx.doi.org/10.1016/j.addr.2012.04.005
   PubMed Web of Science ®Google Scholar
• Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012; 64(1):11-29; PMID:22150668; http://dx.doi.org/10.1111/j.2042-7158.2011.01369.x
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol 2009; 333:369-93; PMID:19768415
   PubMedGoogle Scholar
• Camilloni B, Basileo M, Valente S, Nunzi E, Iorio AM. Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review. Hum Vaccin Immunother 2015; 11(3):553-63; PMID:25714138; http://dx.doi.org/10.1080/21645515.2015.1011562
   PubMed Web of Science ®Google Scholar
• Banchereau R, Baldwin N, Cepika AM, Athale S, Xue Y, Yu CI, Metang P, Cheruku A, Berthier I, Gayet I, et al. Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines. Nat Commun 2014 Oct 22; 5:5283; http://dx.doi.org/10.1038/ncomms6283
   PubMed Web of Science ®Google Scholar
• Frenck RW Jr, Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, Hay CM, Dekker CL, Walter EB Jr, Cate TR, et al. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine 2011 Aug 5; 29(34):5666-74; http://dx.doi.org/10.1016/j.vaccine.2011.06.010
   PubMed Web of Science ®Google Scholar
• Coudeville L, Andre P, Bailleux F, Weber F, Plotkin S. A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes. Hum Vaccin 2010 Oct; 6(10):841-8; http://dx.doi.org/10.4161/hv.6.10.12636
   PubMed Web of Science ®Google Scholar
• Morelon E, Pouteil Noble C, Daoud S, Cahen R, Goujon-Henry C, Weber F, Laurent PE, Kaiserlian D, Nicolas JF. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 2010 Oct 4; 28(42):6885-90; http://dx.doi.org/10.1016/j.vaccine.2010.08.015
   PubMed Web of Science ®Google Scholar
• Manuel O, Humar A, Berutto C, Ely L, Giulieri S, Lien D, Meylan PR, Weinkauf J, Pascual M, Nador R, et al. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant 2011 Jun; 30(6):679-84; http://dx.doi.org/10.1016/j.healun.2011.01.705
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Valle L, de Florentiis D, Parodi V, Murdaca G, Bruzzone B, Durando P, Setti M, Icardi G. Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. Hum Vaccin Immunother 2012 Aug; 8(8):1048-52; http://dx.doi.org/10.4161/hv.20347
   PubMed Web of Science ®Google Scholar
• Jo YM, Song JY, Hwang IS, Lee J, Oh SC, Kim JS, Kim SR, Kim WJ, Cheong HJ. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. J Med Virol 2009 Apr; 81(4):722-7; http://dx.doi.org/10.1002/jmv.21186
   PubMed Web of Science ®Google Scholar
• Marra F, Young F, Richardson K, Marra CA. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza Other Resp Viruses 2013; 7:584-603; http://dx.doi.org/10.1111/irv.12000
   PubMed Web of Science ®Google Scholar
• Pileggi C, Lotito F, Bianco A, Nobile CG, Pavia M. Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials. BMC Infect Dis 2015 Oct 14; 15:427; http://dx.doi.org/10.1186/s12879-015-1161-z
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009 Dec 9; 27(52):7304-12; http://dx.doi.org/10.1016/j.vaccine.2009.10.033
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008 Sep 1; 198(5):650-8; http://dx.doi.org/10.1086/590434
   PubMed Web of Science ®Google Scholar
• Tsang P, Gorse GJ, Strout CB, Sperling M, Greenberg DP, Ozol-Godfrey A, DiazGranados C, Landolfi V. Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial. Vaccine 2014 May 1; 32(21):2507-17; http://dx.doi.org/10.1016/j.vaccine.2013.09.074
   PubMed Web of Science ®Google Scholar
• Hoon Han S, Hee Woo J, Weber F, Joo Kim W, Ran Peck K, Il Kim S, Hwa Choi Y, Myung Kim J. Immunogenicity and safety of Intanza(®)/IDflu(®) intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial. Hum Vaccin Immunother 2013 Sep; 9(9):1971-7; http://dx.doi.org/10.4161/hv.25295
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Orsi A, de Florentiis D, Parodi V, Rappazzo E, Coppelli M, Durando P, Icardi G. Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability. Hum Vaccin Immunother 2013 Mar; 9(3):591-8; http://dx.doi.org/10.4161/hv.23240
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Canepa P, Ceravolo A, Valle L, de Florentiis D, Oomen R, Vogel FR, Denis M, Samson SI, Icardi G. Intanza(®) 15 mg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine 2012 Apr 16; 30(18):2908-13; http://dx.doi.org/10.1016/j.vaccine.2012.02.003
   PubMed Web of Science ®Google Scholar
• Moro PL, Harrington T, Shimabukuro T, Cano M, Museru OI, Menschik D, Broder K. Adverse events after Fluzone ® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013. Vaccine 2013 Oct 9; 31(43):4984-7; http://dx.doi.org/10.1016/j.vaccine.2013.08.001
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age. Vaccine 2013 Dec 5; 31(50):6034-40; http://dx.doi.org/10.1016/j.vaccine.2013.09.012
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age. Vaccine 2013 May 1; 31(19):2358-65; http://dx.doi.org/10.1016/j.vaccine.2013.03.008
   PubMed Web of Science ®Google Scholar
• Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther 2011 Aug; 28(8):640-9; http://dx.doi.org/10.1007/s12325-011-0042-0
   PubMed Web of Science ®Google Scholar
• Durando P, Alicino C, Alberti M, Sticchi L, Turello V, Marensi L, Caiazzo AL, Panico MG, Giugliano F, Parlato A, Peluso F, Sgricia S, Icardi G; Italian Intradermal Influenza Vaccine Working Group. Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study. Adv Ther 2012 Apr; 29(4):312-26; http://dx.doi.org/10.1007/s12325-012-0012-1
   PubMed Web of Science ®Google Scholar
• Arnou R, Frank M, Hagel T, Prébet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011 Jul; 28(7):555-65; http://dx.doi.org/10.1007/s12325-011-0035-z
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Wu X. The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults. Vaccine 2013 Jan; 31(6):857-60; http://dx.doi.org/10.1016/j.vaccine.2012.12.028
   PubMed Web of Science ®Google Scholar
• Zahn M, Pursiful P, Carrico R, Woods C, Troutman A. Self-immunization with live attenuated influenza vaccine in a mass vaccination clinic. Dis Med Public Health Preparedness 2013 Apr; 7(2):215-7; http://dx.doi.org/10.1017/dmp.2013.25
   PubMed Web of Science ®Google Scholar
• Coleman BL, McGeer AJ, Halperin SA, Langley JM, Shamout Y, Taddio A, Shah V, McNeil SA. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine 2012 Sep 28; 30(44):6287-93; http://dx.doi.org/10.1016/j.vaccine.2012.08.006
   PubMed Web of Science ®Google Scholar
• Dhont PA, Albert A, Brenders P, Podwapinska A, Pollet A, Scheveneels D, Tihon F, Verheyden I, Victor J, Samson SI. Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010-2011 influenza season. Adv Ther 2012 Jun; 29(6):562-77; http://dx.doi.org/10.1007/s12325-012-0025-9
   PubMed Web of Science ®Google Scholar
• Coleman BL, McNeil SA, Langley JM, Halperin SA, McGeer AJ. Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers. Vaccine 2015 Nov 27; 33(48):6635-40; http://dx.doi.org/10.1016/j.vaccine.2015.10.095
   PubMed Web of Science ®Google Scholar
• Richard SA, Viboud C, Miller MA. Evaluation of Southern Hemisphere influenza vaccine recommendations. Vaccine 2010; 28(15):2693-9; PMID:20153352; http://dx.doi.org/10.1016/j.vaccine.2010.01.053
   PubMed Web of Science ®Google Scholar
• Mosnier A, Caini S, Daviaud I, Nauleau E, Bui TT, Debost E, Bedouret B, Agius G, van der Werf S, Lina B, et al. Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections. PLoS One 2015 Sep 1; 10(9):e0136186; http://dx.doi.org/10.1371/journal.pone.0136186
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Falsey AR, Ozol-Godfrey A, Landolfi V, Tsang PH. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults. Vaccine 2015 Feb 25; 33(9):1151-9; http://dx.doi.org/10.1016/j.vaccine.2015.01.025
   PubMed Web of Science ®Google Scholar
• Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. Vaccine 2013 Jan 21; 31(5):770-6; http://dx.doi.org/10.1016/j.vaccine.2012.11.074
   PubMed Web of Science ®Google Scholar
• Chen D, Bowersock T, Weeratna R, Yeoh T. Current opportunities and challenges in intradermal vaccination. Ther Deliv 2015 Sep; 6(9):1101-8; http://dx.doi.org/10.4155/tde.15.65
   PubMedGoogle Scholar
• Young F, Marra F. A systematic review of intradermal influenza vaccines. Vaccine 2011 Nov 8; 29(48):8788-801; http://dx.doi.org/10.1016/j.vaccine.2011.09.077
   PubMed Web of Science ®Google Scholar
• Weniger BG, Papania MJ. Alternative vaccine delivery methods. In: Plotkin SA, Orenstein WA, Offi PA, editors. Vaccines. 6th edition. New York, NY: Elsevier; 2013. pp. 1200-31
   Google Scholar
• Banchereau J, Klechevsky E, Schmitt N, Morita R, Palucka K, Ueno H. Harnessing human dendritic cell subsets to design novel vaccines. Ann N Y Acad Sci 2009 Sep; 1174:24-32; http://dx.doi.org/10.1111/j.1749-6632.2009.04999.x
   PubMed Web of Science ®Google Scholar
• Teunissen MBM. Intradermal immunization. Düsseldorf, Germany: Springer-Verlag; 2012
   Google Scholar